步步惊心：丽

华森制药：收到药品再注册批准通知书_我的网站

A |     Nearly half of all injuries reported from electric bikes in the last six years took place in 2022, according to a new report from the Consumer Product Safety Commission (CPSC).The CPSC estimates more than 360,000 injuries related to micromobility devices were treated in emergency rooms across the country between 2017 to 2022.According to the report, injuries rose more than 20% in 2022, compared to the year prior.There have been at least 233 deaths associated with e-bikes, e-scooters and hoverboards from 2017 through 2022, the report said. CPSC acknowledged that reporting on deaths associated with the devices is "ongoing and incomplete."This comes as sales and usage of e-bikes, e-scooters and hoverboards are on the rise, according to the market research firm Circana, the U.S. e-bike market grew 269% between 2019 and 2022, with $885.5 million in sales last year.CPSC's report also highlighted "significant" fire hazards from the devices – CPSC said it was aware of at least 19 deaths associated with micromobility device fires from 2021 through late November 2022.Last year, CPSC called on more than 2,000 manufacturers and distributors of the devices to review their product lines and ensure they comply with voluntary safety standards "to reduce the serious risk of dangerous fires with these products."CPSC also "urged" consumers to take steps to prevent fires from e-bikes, e-scooters, and hoverboards by always being present when charging the devices and only using approved battery replacements.ABC News' Meredith Deliso contributed to this report.。    华森制药8月25日公告称，公司近日收到重庆市药品监督管理局核准签发的关于产品注射用二乙酰氨乙酸乙二胺(0.2g和0.4g)的《药品再注册批准通知书》。该药品适用于预防和治疗各种原因出血。本次获得再注册批准将确保药品正常生产和销售，短期内不会对公司经营业绩产生重大影响。

Current article:http://www.lichuorenrenyitankanmeimu.cfd/e62vp1v/w397yk.xls

Published on:12:50:33